Skip to main content
Home
  • About
    Us
    • Overview
    • Our Leadership
  • Patients
    & Families
    • Overview
    • Lysosomal Disorders
    • Understanding Gaucher Disease
      • Overview
      • Living With Gaucher Disease (GD1)
      • Living With Gaucher Disease (GD3)
    • Understanding Hunter Syndrome
    • Understanding Pompe Disease
    • Patient Advocacy & Engagement
    • Patient Early Access Policy
  • Our
    Approach
    • Overview
    • Treating the Whole Body
    • The plato® Platform
    • HSC Gene Therapy
    • Targeting Lysosomal Disorders
  • Our
    Pipeline
    • Overview
  • Work
    with Us
  • Our
    Views
    • Overview
    • The Vector Space Blog
    • Ideas and Insights
  • Investors & Media
  • Contact Us
  • Investors & Media
  • Contact Us

Contact Us

We’d like to hear from you!

For general questions: [email protected]

To reach our patient advocacy team: [email protected]

For media inquiries: [email protected]

For health care practitioners with questions: [email protected]

Our headquarters:

100 Technology Square
6th Floor
Cambridge, MA, 02139, USA
Phone: 617.914.8420

Home

Follow Us

Learn more

Sign up for news alerts

  • Terms of Use
  • Privacy Notice
  • Cookie Policy
  • Sitemap

©2024 AVROBIO, Inc.
All rights reserved.

You are now leaving AVROBIO’s website.

The third party website to which you will be directed is not affiliated with AVROBIO, and AVROBIO assumes no responsibility for information or statements on third parties’ websites. Thank you for visiting theavrobio.org.

Continue to URL Cancel

CloseToday is MPS Awareness Day (MPS II is also known as Hunter syndrome) and we want to recognize the incredible work that patient advocacy groups do year-round to support the Hunter syndrome community.

Learn more about Hunter syndrome and the patient advocacy groups’ efforts here:

  • Canadian MPS Society for Mucopolysaccharide and Related Diseases
  • Casa Hunter
  • MPS Society UK
  • National MPS Society
  • Project Alive
  • MPS España
  • National Organization for Rare Disorders
  • Global Genes
  • About
    Us
    • Overview
    • Our Leadership
  • Patients
    & Families
    • Overview
    • Lysosomal Disorders
    • Understanding Gaucher Disease
      • Overview
      • Living With Gaucher Disease (GD1)
      • Living With Gaucher Disease (GD3)
    • Understanding Hunter Syndrome
    • Understanding Pompe Disease
    • Patient Advocacy & Engagement
    • Patient Early Access Policy
  • Our
    Approach
    • Overview
    • Treating the Whole Body
    • The plato® Platform
    • HSC Gene Therapy
    • Targeting Lysosomal Disorders
  • Our
    Pipeline
    • Overview
  • Work
    with Us
  • Our
    Views
    • Overview
    • The Vector Space Blog
    • Ideas and Insights
  • Investors & Media
  • Contact Us